Corcept Therapeutics Incorporated (CORT)

Current ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total current assets	US$ in thousands	458,636	431,527	432,588	533,893	499,253	452,402	419,045	388,220	266,463	401,900	411,270	409,624	478,501	463,493	438,333	344,776	307,358	267,310	232,655	216,864
Total current liabilities	US$ in thousands	104,505	121,873	93,059	78,865	72,491	53,068	49,057	57,244	47,541	44,757	45,402	40,601	47,494	43,048	42,243	34,075	38,841	32,396	30,381	34,218
Current ratio		4.39	3.54	4.65	6.77	6.89	8.52	8.54	6.78	5.60	8.98	9.06	10.09	10.07	10.77	10.38	10.12	7.91	8.25	7.66	6.34

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $458,636K ÷ $104,505K
= 4.39

The current ratio of Corcept Therapeutics Inc has fluctuated over the past eight quarters, ranging from 3.54 to 8.54. The current ratio measures the company's ability to cover its short-term liabilities with its current assets.

In Q4 2023, the current ratio was 4.39, indicating that the company had $4.39 in current assets for every $1 in current liabilities. This was a decrease from the previous quarter, suggesting a potential strain on the company's liquidity.

The highest current ratio in the period was 8.54 in Q3 2022, which indicates a strong ability to meet short-term obligations. A current ratio above 1 is generally considered healthy, but a very high ratio could suggest that a company is not effectively utilizing its current assets.

Overall, the current ratio of Corcept Therapeutics Inc has shown some volatility, with recent quarters indicating a lower ability to cover short-term obligations compared to previous periods. Further analysis would be needed to assess the reasons for these fluctuations and their potential impact on the company's financial health.